GlassScriptPhysician profile
Anne T Riordan
NPI 1609985290
$7,228.03
in general payments reported to CMS, 2019-2025
33 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $701 · 2021: $814 · 2022: $1,247 · 2023: $839 · 2024: $1,075 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,305 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,305.39 |
| Education | $104.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,545.73 | 2019-2025 | Skyrizi, Rinvoq, Humira |
| Galderma Laboratories, L.P. | $898.84 | 2019-2024 | Epsolay, Aklief, Twyneo |
| Janssen Biotech, INC. | $597.21 | 2019-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $541.36 | 2022-2025 | Sotyktu |
| Pfizer INC. | $450.45 | 2019-2025 | |
| Journey Medical Corporation | $316.71 | 2020-2023 | |
| Amgen INC. | $277.27 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $258.78 | 2019-2023 | Ilumya, Winlevi |
| Organogenesis INC. | $248.56 | 2024-2025 | Puraply Wound Matrix |
| Almirall LLC | $224.21 | 2019-2024 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.31 | 2023-2025 | Spevigo |
| Incyte Corporation | $186.97 | 2022-2025 | Opzelura |
| Ucb, INC. | $169.70 | 2019-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $130.34 | 2019-2025 | |
| Kerecis Limited | $126.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $124.24 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $110.52 | 2021-2022 | |
| Lilly USA, LLC | $110.32 | 2019-2025 | Ebglyss, Taltz, Zepbound |
| Leo Pharma INC. | $103.13 | 2019-2021 | |
| Biofrontera INC. | $87.57 | 2023-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Mayne Pharma Commercial LLC | $79.41 | 2022-2023 | |
| Organon LLC | $63.29 | 2025 | Vtama |
| Epi Health, LLC | $62.40 | 2021-2022 | |
| Mission Pharmacal Company | $61.18 | 2019 | |
| Allergan, INC. | $51.53 | 2019-2022 | |
| Genzyme Corporation | $50.60 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.26 | 2019 | |
| Arcutis Biotherapeutics, INC. | $33.98 | 2025 | Zoryve |
| Taro Pharmaceuticals USA, INC. | $24.19 | 2019 | |
| Botanix Sb INC | $16.67 | 2025 | Sofdra |
| Mindray Ds USA, INC. | $14.87 | 2024 | A7 Anesthesia System |
| Vyne Pharmaceuticals INC. | $11.42 | 2020 | |
| Sensus Healthcare, INC. | $4.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Riordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.